| DRUG WATCH |
|
| Year : 2012 | Volume
: 44
| Issue : 5 | Page : 649-650 |
Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia
Gajanan Kulkarni, Janardhanan C Narayanaswamy, Suresh Bada Math
Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India
Correspondence Address:
Janardhanan C Narayanaswamy
Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7613.100406
There are reports of de novo development or exacerbation of obsessive-compulsive symptoms in patients with schizophrenia treated with atypical antipsychotics, although this is widely debated. We report one such case where a patient with a primary diagnosis of schizophrenia, treated with olanzapine, developed de novo obsessive-compulsive disorder, with convincing evidence for its causality due to the drug.
[FULL TEXT] [PDF]*
|
